In a nutshell This trial looked at the long-term outcomes of sacral neuromodulation (SNM) for patients with overactive bladder (OAB). The authors found that SNM was a minimally invasive procedure with good long-term success rates. Some background SNM one of several treatment options for the symptoms of OAB, retention and voiding issues...
Read More
In a nutshell This study reviewed treatment options for the treatment of overactive bladder (OAB) in men. Researchers suggested that mirabegron (Myrbetriq) is associated with increased effectiveness and safety in these patients. Some background OAB consists of a frequent and sudden urge to urinate that is difficult to control. Urgency...
Read More
In a nutshell This study looked at the long-term safety and effectiveness of 75mg vibegron (Gemtesa) for the treatment of overactive bladder (OAB). The authors found that vibegron demonstrated favorable long-term safety, tolerability, and effectiveness in patients with OAB. Some background OAB involves urinary symptoms such...
Read More
In a nutshell This paper investigated the effectiveness and safety of mirabegron (Myrbetriq) as an add-on treatment to tamsulosin (Flomax) for the treatment of overactive bladder (OAB) in men with lower urinary tract symptoms (LUTS). This study found that mirabegron appeared to be effective for the treatment of OAB symptoms in those treated with...
Read More
In a nutshell This paper investigated the effectiveness and safety of mirabegron (Myrbetriq) as an add-on treatment to tamsulosin (Flomax) for the treatment of overactive bladder (OAB) in men with lower urinary tract symptoms (LUTS). This study found that mirabegron appeared to be effective for the treatment of OAB symptoms in those treated with...
Read More
In a nutshell This study reviewed the effectiveness and safety of percutaneous tibial nerve stimulation (PTNS) for the treatment of overactive bladder (OAB). Researchers suggested that PTNS is a good and safe treatment method for these patients. Some background The OAB syndrome occurs in around 23% of the US population. It consists of a...
Read More
In a nutshell This study investigated the effectiveness and safety of increasing the dose of solifenacin (Vesicare) treatment in male patients with overactive bladder (OAB) that does not respond to low-dose treatment. Researchers suggested that increasing the dose of solifenacin is safe and improves the outcomes of these patients. Some...
Read More
In a nutshell This study investigated the association between smoking and urinary symptoms in women with overactive bladder (OAB). Researchers suggested that urgency and urine leakage was associated with age and smoking habits. Some background OAB consists of a sudden, uncontrolled need to urinate. Some people have incontinence (leakage of urine) and...
Read More
In a nutshell This study investigated the effectiveness and safety of sacral neuromodulation (SNM) with the InterStim system in the treatment of overactive bladder (OAB) in real-world practice. Researchers suggested that this treatment is associated with improved effectiveness and quality of life in these patients. Some background Overactive bladder...
Read More
In a nutshell This study investigated the effectiveness and impact on patient satisfaction of mirabegron (Myrbetriq) in patients with overactive bladder (OAB). Researchers suggested that this drug improved the treatment satisfaction of patients with OAB. Some background OAB consists of an uncontrollable need to urinate with or without incontinence...
Read More
In a nutshell This study reviewed the outcomes of onabotulinumtoxinA (BTX) and sacral neuromodulation (SNM) in the treatment of overactive bladder (OAB). Researchers suggested that both treatments improved the outcomes of these patients, but BTX may be associated with more complications. Some background OAB of an uncontrolled need to urinate...
Read More
In a nutshell This study investigated whether medication for overactive bladder (OAB) is associated with dementia. Researchers suggested that the use of anticholinergic medication might increase the risk of dementia compared to beta-3 agonist users. Some background OAB consists of a frequent and sudden urge to urinate that is difficult to control. It...
Read More
